Riding a wave of interest in mental health tech, companies creating VR content for therapeutic outcomes are receiving a deluge of attention and funding. And, while VR has been used successfully to treat post-traumatic stress disorder (PTSD) since the 1990s, these new programs address a much broader range of conditions. The library of Palo Alto–based Limbix, for instance, includes VR content designed to treat issues including alcohol addiction, claustrophobia and teenage depression. Barcelona-based Psious offers treatments for eating disorders.
Today’s VR content is primarily designed to aid exposure therapy, a treatment for anxiety disorders in which patients are exposed to anxiety-inducing stimuli in a safe, controlled environment, eventually learning that the “threats” they’re worried about are not actually very dangerous. For example, someone who fears heights might visit progressively taller buildings under the guidance of their therapist (in vivo exposure), while someone with PTSD might revisit traumatic memories in therapy sessions (imaginary exposure).
Comments